Trimethoprim Export Market Intelligence: India's 278 Suppliers Shipping to 121 Countries — TransData Nexus 2026

Q: Who are the top trimethoprim exporters from India?

The top trimethoprim exporters from India are: 1. MICRO LABS LIMITED — $7.5M (28.4% market share); 2. LEBEN LABORATORIES PRIVATE LIMITED — $1.2M (4.5% market share); 3. MEDICAMEN BIOTECH LIMITED — $1.2M (4.4% market share); 4. AUROBINDO PHARMA LIMITED — $1.1M (4.2% market share); 5. FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED — $1.1M (4.0% market share). Together they account for 45.4% of India's total trimethoprim export value.

Q: What is the total export value of trimethoprim from India?

The total export value of trimethoprim from India is $26.4M USD, recorded across 2,427 shipment transactions from 278 active exporters to 121 destination countries. The average shipment value is $10.9K.

Q: Which countries import trimethoprim from India?

India exports trimethoprim to 121 countries worldwide. The top importing countries are: UNITED STATES (15.4% share, $4.1M), ZIMBABWE (14.9% share, $3.9M), ETHIOPIA (8.8% share, $2.3M), TANZANIA (4.3% share, $1.1M), SOUTH AFRICA (4.1% share, $1.1M). These five markets account for 47.5% of total export value.

Q: What is the HS code for trimethoprim exports from India?

The primary HS code for trimethoprim exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of trimethoprim exports from India?

The average unit price for trimethoprim exports from India is $8.75 USD per unit, with prices ranging from $0.01 to $840.31 depending on formulation, packaging, and order volume. The total market is valued at $26.4M across 2,427 shipments.

Q: Which ports handle trimethoprim exports from India?

The primary ports for trimethoprim exports from India are SAHAR AIR (14.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (11.9% of shipments), DELHI AIR CARGO ACC (INDEL4) (11.5% of shipments), NHAVA SHEVA SEA (INNSA1) (7.2% of shipments), DELHI AIR (5.4% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of trimethoprim?

India is one of the world's leading exporters of trimethoprim due to its large base of 278 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports trimethoprim to 121 countries, demonstrating 62% global market coverage.

Q: What certifications do Indian trimethoprim exporters need?

Indian trimethoprim exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import trimethoprim from India?

There are 515 registered buyers importing trimethoprim from India, spread across 121 countries. The repeat buyer rate is 58.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top trimethoprim supplier from India?

MICRO LABS LIMITED is the leading trimethoprim exporter from India with a market share of 28.4% and total export value of $7.5M across 115 shipments. The top 5 suppliers together control 45.4% of total export value.

Suresh Sormare

Trimethoprim

India Pharmaceutical Trade Intelligence

$26.4M278 Suppliers121 CountriesHS 30049099

ExportsIndia → UNITED STATES15.4%India → ZIMBABWE14.9%

ImportsGERMANY → India$462.3K UNITED STATES → India$6.3K

#1 Supplier: MICRO LABS #1 Buyer: MINISTRY OF

Trimethoprim Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Trimethoprim to the World

Between 2022 and 2026, India exported $26.4M worth of trimethoprim across 2,427 verified shipments to 121 countries — covering 62% of world markets in the Advanced Antibiotics segment. The largest destination is UNITED STATES (15.4%). MICRO LABS LIMITED leads with a 28.4% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Trimethoprim export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Trimethoprim export data snapshot — $26.4M · 278 exporters · 121 countriesTransData Nexus · Indian Customs Data

Top Trimethoprim Exporters from India

278 active exporters · Ranked by export value

View all 278 →

Top Trimethoprim Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MICRO LABS LIMITED	$7.5M	115	19	28.4%
2	LEBEN LABORATORIES PRIVATE LIMITED

Top Countries Importing Trimethoprim from India

121 destination markets · Ranked by import value

All 121 countries →

Top Countries Importing Trimethoprim from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$4.1M	15.4%
2	ZIMBABWE	$3.9M	14.9%
3	ETHIOPIA	$2.3M	8.8%
4	TANZANIA	$1.1M	4.3%
5	SOUTH AFRICA	$1.1M	4.1%
6	CAMEROON	$953.5K	3.6%
7	FRANCE	$810.4K	3.1%
8	BURUNDI	$754.1K	2.9%
9	SENEGAL	$704.0K	2.7%
10	BURKINA FASO	$682.2K	2.6%

UNITED STATES is India's largest trimethoprim export destination, absorbing 15.4% of total exports worth $4.1M. The top 5 importing countries — UNITED STATES, ZIMBABWE, ETHIOPIA, TANZANIA, SOUTH AFRICA — together account for 47.5% of India's total trimethoprim export value. The remaining 116 destination countries collectively receive the other 52.5%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Trimethoprim to India?

6 origin countries · Total import value: $472.0K

India imports trimethoprim from 6 countries with a combined import value of $472.0K. The largest supplier is GERMANY ($462.3K, 24 shipments), followed by UNITED STATES and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Trimethoprim to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$462.3K	24	97.9%
2	UNITED STATES	$6.3K	38	1.3%
3	UNITED KINGDOM	$3.3K	5	0.7%
4	SOUTH AFRICA	$93	11	0.0%
5	BANGLADESH	$49	2	0.0%
6	AUSTRALIA	$9	1	0.0%

GERMANY is the largest supplier of trimethoprim to India, accounting for 97.9% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, UNITED KINGDOM, SOUTH AFRICA, BANGLADESH — together supply 100.0% of India's trimethoprim imports. Click any country to see detailed supplier and buyer data for that import corridor.

Trimethoprim — Export Intelligence Video

Visual overview of India's trimethoprim import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's trimethoprim pharmaceutical import and export market — $26.4M in total trade, 278 verified manufacturers, and 121 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Trimethoprim

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, trimethoprim is approved for various indications, including urinary tract infections and certain respiratory infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for trimethoprim, indicating a competitive generic market. Notably, there have been recent approvals, such as [specific approval details with dates].

Regarding import alerts, as of March 2026, there are no specific FDA import alerts targeting trimethoprim from India. However, manufacturers must ensure compliance with FDA regulations to avoid potential detentions. The FDA's Import Alert 66-66, issued in October 2024, emphasizes the importance of proper labeling for active pharmaceutical ingredients (APIs) to prevent misbranding under section 502(f)(1) of the FD&C Act.

Given the presence of 278 active Indian exporters, maintaining stringent quality control and regulatory compliance is crucial to sustain market access and competitiveness in the U.S.

2EU & UK Regulatory Framework

In the European Union, trimethoprim is subject to marketing authorization requirements overseen by the European Medicines Agency (EMA). A notable regulatory action includes the Periodic Safety Update Report Single Assessment (PSUSA) for trimethoprim, concluded in November 2025, which resulted in variations to the product information to enhance safety and efficacy. (ema.europa.eu)

The United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) continues to align with EU standards post-Brexit, requiring similar marketing authorizations and adherence to Good Manufacturing Practice (GMP) guidelines.

3WHO Essential Medicines & Global Standards

Trimethoprim is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. The 22nd edition, published in September 2021, lists trimethoprim for the treatment of lower urinary tract infections. (iris.who.int)

Manufacturers must ensure that trimethoprim formulations comply with international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to meet quality and safety requirements across different markets.

4India Regulatory Classification

In India, trimethoprim is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, trimethoprim is not listed under the Drug Price Control Order (DPCO), allowing manufacturers to set prices based on market dynamics.

For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) for certain pharmaceutical products. While trimethoprim is not currently subject to export restrictions, exporters should stay informed about regulatory changes that may impact export requirements.

5Patent & Exclusivity Status

Trimethoprim's primary patents have expired, leading to a robust generic market with multiple manufacturers producing the drug. This competitive landscape necessitates adherence to stringent quality standards and regulatory compliance to maintain market share.

6Recent Industry Developments

In November 2025, the EMA concluded a PSUSA for trimethoprim, resulting in updates to product information to enhance safety and efficacy. (ema.europa.eu)

In October 2024, the FDA issued Import Alert 66-66, focusing on APIs that appear to be misbranded due to labeling deficiencies. This alert underscores the importance of compliance with labeling requirements to avoid import detentions.

In September 2021, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of trimethoprim for treating lower urinary tract infections, highlighting its continued relevance in global health. (iris.who.int)

These developments emphasize the need for manufacturers and exporters to stay abreast of regulatory changes and ensure compliance to maintain market access and competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Trimethoprim

Retail & reference prices across 9 markets vs. India FOB export price of $8.75/unit

Global Price Benchmark for Trimethoprim across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$0.56	USD	According to the FDA Orange Book, Trimethoprim is an approved generic medication, contributing to its affordability in the U.S. market.
United Kingdom	$0.65	GBP	The NHS Drug Tariff, as of March 2026, lists Trimethoprim 200 mg tablets at £0.50 per unit, reflecting the UK's commitment to cost-effective generic medications.
Germany	$0.66	EUR	The German Federal Institute for Drugs and Medical Devices (BfArM) includes Trimethoprim in its list of approved generics, ensuring competitive pricing within the German healthcare system.

Supply Chain Risk Assessment — Trimethoprim

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Trimethoprim, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of India's APIs and KSMs are sourced from China, making the supply chain vulnerable to disruptions. This dependency exposes the industry to risks such as geopolitical tensions, trade restrictions, and environmental regulations affecting Chinese manufacturing.

In response, the Indian government has initiated the Production Linked Incentive (PLI) scheme to bolster domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme, aiming to reduce import dependence by half for critical pharmaceutical ingredients. While these efforts are promising, the transition to self-sufficiency is gradual, and the industry remains susceptible to external supply chain shocks in the interim.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters of Trimethoprim from India account for 45.4% of total exports, with MICRO LABS LIMITED alone contributing 28.4%. This concentration suggests a moderate risk of supply disruption if any of these key suppliers face operational challenges.

The PLI scheme, launched in 2020, aims to diversify and strengthen the supplier base by incentivizing domestic production of APIs and KSMs. However, as of March 2026, the scheme's impact on reducing supplier concentration in the Trimethoprim market remains limited, necessitating continued monitoring and strategic planning to mitigate single-source risks.

Access Complete Trimethoprim Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,427 transactions across 121 markets.

Request Demo View Pricing

Frequently Asked Questions — Trimethoprim Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top trimethoprim exporters from India?

The leading trimethoprim exporters from India are MICRO LABS LIMITED, LEBEN LABORATORIES PRIVATE LIMITED, MEDICAMEN BIOTECH LIMITED, and 11 others. MICRO LABS LIMITED leads with 28.4% market share ($7.5M). The top 5 suppliers together control 45.4% of total export value.

What is the total export value of trimethoprim from India?

The total export value of trimethoprim from India is $26.4M, recorded across 2,427 shipments from 278 active exporters to 121 countries. The average shipment value is $10.9K.

Which countries import trimethoprim from India?

India exports trimethoprim to 121 countries. The top importing countries are UNITED STATES (15.4%), ZIMBABWE (14.9%), ETHIOPIA (8.8%), TANZANIA (4.3%), SOUTH AFRICA (4.1%), which together account for 47.5% of total export value.

What is the HS code for trimethoprim exports from India?

The primary HS code for trimethoprim exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Trimethoprim

Trimethoprim

Top Trimethoprim Exporters from India

Top Countries Importing Trimethoprim from India

Who Supplies Trimethoprim to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Trimethoprim — Export Intelligence Video

Regulatory Landscape — Trimethoprim

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Trimethoprim

Supply Chain Risk Assessment — Trimethoprim

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Trimethoprim Trade Intelligence

Frequently Asked Questions — Trimethoprim Exports from India

Who are the top trimethoprim exporters from India?

What is the total export value of trimethoprim from India?

Which countries import trimethoprim from India?

What is the HS code for trimethoprim exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of trimethoprim exports from India?

Which ports handle trimethoprim exports from India?

Why is India a leading exporter of trimethoprim?

What certifications do Indian trimethoprim exporters need?

How many buyers import trimethoprim from India?

What is the market share of the top trimethoprim exporter from India?

Analysis Methodology